Bayer's Crop Science Unit Drives Strong Results -- Market Talk

Dow Jones11-12

1115 GMT - Strong results for Bayer's crop science segment helped offset a guidance cut for its consumer-health unit, JPMorgan analysts write in a note. A decline in the costs of goods sold, improved spending efficiencies and lower-than-expected reconciliation costs also supported the generally strong third quarter, the bank says. The German healthcare-and-agriculture company's significant exposure to challenging markets in the U.S. and China undercut consumer-health performance and contributed to the weaker outlook, Chief Financial Officer Wolfgang Nickl said in a call following the results. Shares rise 4.5% to trade at 28.67 euros. (william.gray@wsj.com)

 

(END) Dow Jones Newswires

November 12, 2025 06:15 ET (11:15 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment